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Reasons for drug policy reform: prohibition enables
systemic human rights abuses and undermines public
health
Harsh enforcement of prohibition undermines the right to health and fundamental dignity, write
Dainius P ras and Julie Hannah
Dainius Pūras UN special rapporteur on the right to health 1 2, Julie Hannah co-director 2
1Centre for Child Psychiatry and Social Pediatrics, Vilnius University, Lithuania; 2International Centre on Human Rights and Drug Policy, Human
Rights Centre, University of Essex, Colchester, UK
Drug prohibition, including criminalisation to regulate the supply
and demand of controlled substances, has had devastating effects
on human rights and public health worldwide.
Prohibition as an international policy response gives rise to
illicit drugmarkets governed by criminal networks and regulated
by violence. The poor and marginalised communities in which
illicit drugs are cultivated, transited, or sold are
disproportionately affected. States have responded with
increased law enforcement, escalating violence and further
destabilising communities. Parallel violent pursuits both to
protect and to topple illicit markets have been linked to large
scale displacement, femicide, and an overall decrease in life
expectancy, such as in Mexico.1
Mass incarceration to enforce prohibition has overburdened
criminal justice systems and left countless people languishing
in deplorable facilities in inhumane conditions around the
world.2Criminalisation of possessionmeans that a fifth of people
who use drugs spend much of their lives cycling through the
criminal justice system, with serious social, economic, and
health consequences. In prisons, people who inject drugs have
limited or no access to healthcare, including harm reduction
interventions such as clean needles and opioid substitution
treatment.3 4
Custodial settings are a high risk environment for transmission
of HIV and hepatitis C, particularly for people who inject drugs,
and these infections have broader public health consequences
once people are released.1 Despite the devastating health and
human rights effects, incarceration has failed to deter drug
consumption or trafficking.
Outside the criminal justice system, the pursuit of prohibition
has given rise to compulsory detention centres, where people
identified as drug users may be held without due process and
subjected to torture, physical and sexual violence, and forced
labour in the name of “treatment.” In East and South East Asia
alone, an estimated 250 000 people are held in these facilities
despite evidence of their ineffectiveness in treating drug
dependence.5 13Compulsory detention of drug users violates the
right to health and is inhuman, degrading, and “inherently
arbitrary” under international human rights law.56
Outside prison, criminalisation and stigma associated with drug
use have been recurrent barriers to accessing healthcare,
including scientifically proved harm reduction treatment.7
Punitive models of drug control such as registries of drug users,
reporting requirements for health professionals, legal bans on
the provision of substitution treatment, and police raids near
healthcare facilities deter people from accessing healthcare,
driving drug use underground and increasing health risks.8
Prohibition has been linked to a growing epidemic of opioid
overdose in North America, where unnecessary restrictions on
overdose treatment, lack of substitution treatment, and
aggressive policing contribute to preventable mortality.1
Laws banning opioids such as methadone and morphine for
medically indicated treatment and regulations unnecessarily
restricting their prescription or use undermine healthcare
professionals in the delivery of ethical healthcare As a result,
four fifths of the world lack adequate access to drugs for
palliative care and slightly less than half of countries worldwide
have frameworks in place to enable the provision of opioid
substitution treatment.9
Bold initiatives have emerged in recent years that show there
are other ways to tackle the complex dimensions of drugs that
can reduce harms and improve public health outcomes. In
countries such as the Czech Republic, Switzerland, and Portugal,
longstanding decriminalisation models based on public health
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have reduced transmission of infectious disease, mortality, and
criminality and placed the individual at the heart of the
response.1
Likewise, communities and individuals from the frontlines of
prohibition have used human rights to mobilise and demand
reform to secure their health and wellbeing. In 2011, community
health activists successfully challenged the ban on supervised
injecting facilities in western Canada, the first of two facilities
now operating in North America.10After innovative community
mobilisation efforts, three courageous activists recently
challenged Russia’s legal ban on opioid substitution treatment
and are awaiting a decision from the European Court of Human
Rights.11
Behind these community efforts to bring about change,
healthcare professionals had a crucial role. Looking ahead, in
this era of drug reform, professionals must be guided by their
legal and ethical responsibilities to champion the health and
dignity of the people they serve. They are duty bound to lead
in efforts to combat societal prejudices and enable reforms that
rightfully centre on individuals and communities.
Drug prohibition and criminalisation is a failed policy model.
It is now time for decriminalisation and the move towards legal
regulation of controlled substances.
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